BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lappano R, Jacquot Y, Maggiolini M. GPCR Modulation in Breast Cancer. Int J Mol Sci 2018;19:E3840. [PMID: 30513833 DOI: 10.3390/ijms19123840] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Shapiro BD, Battle A. Bayesian Multi-View Clustering given complex inter-view structure. F1000Res 2022;11:1460. [DOI: 10.12688/f1000research.126215.1] [Reference Citation Analysis]
2 Karaglani M, Panagopoulou M, Baltsavia I, Apalaki P, Theodosiou T, Iliopoulos I, Tsamardinos I, Chatzaki E. Tissue-Specific Methylation Biosignatures for Monitoring Diseases: An In Silico Approach. Int J Mol Sci 2022;23:2959. [PMID: 35328380 DOI: 10.3390/ijms23062959] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Dang HH, Ta HDK, Nguyen TTT, Anuraga G, Wang CY, Lee KH, Le NQK. Identifying GPSM Family Members as Potential Biomarkers in Breast Cancer: A Comprehensive Bioinformatics Analysis. Biomedicines 2021;9:1144. [PMID: 34572330 DOI: 10.3390/biomedicines9091144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
4 Lyu C, Ye Y, Lensing MM, Wagner K, Weigel RJ, Chen S. Targeting Gi/o protein-coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy.. [DOI: 10.1101/2021.06.15.448534] [Reference Citation Analysis]
5 Bostanabad SY, Noyan S, Dedeoglu BG, Gurdal H. Overexpression of β-Arrestins inhibits proliferation and motility in triple negative breast cancer cells. Sci Rep 2021;11:1539. [PMID: 33452359 DOI: 10.1038/s41598-021-80974-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
6 Muthiah I, Rajendran K, Dhanaraj P, Vallinayagam S. In silico structure prediction, molecular docking and dynamic simulation studies on G Protein-Coupled Receptor 116: a novel insight into breast cancer therapy. J Biomol Struct Dyn 2021;39:4807-15. [PMID: 32580684 DOI: 10.1080/07391102.2020.1783365] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ren H, Hu D, Mao Y, Su X. Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis. Med Sci Monit 2020;26:e920212. [PMID: 32251269 DOI: 10.12659/MSM.920212] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
8 Deng M, Zhang Z, Liu B, Hou K, Che X, Qu X, Liu Y, Hu X, Zhang Y, Lv Q. Localization of GPSM2 in the Nucleus of Invasive Breast Cancer Cells Indicates a Poor Prognosis. Front Oncol 2020;10:227. [PMID: 32195179 DOI: 10.3389/fonc.2020.00227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Kostenis E, Pfeil EM, Annala S. Heterotrimeric Gq proteins as therapeutic targets? J Biol Chem 2020;295:5206-15. [PMID: 32122969 DOI: 10.1074/jbc.REV119.007061] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
10 Soond SM, Zamyatnin AA Jr. Targeting G protein-coupled receptors in cancer therapy. Adv Cancer Res 2020;145:49-97. [PMID: 32089165 DOI: 10.1016/bs.acr.2019.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Li M, Wang X, Ma RR, Shi DB, Wang YW, Li XM, He JY, Wang J, Gao P. The Olfactory Receptor Family 2, Subfamily T, Member 6 (OR2T6) Is Involved in Breast Cancer Progression via Initiating Epithelial-Mesenchymal Transition and MAPK/ERK Pathway. Front Oncol 2019;9:1210. [PMID: 31781505 DOI: 10.3389/fonc.2019.01210] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
12 O'Brien JB, Wilkinson JC, Roman DL. Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials. J Biol Chem 2019;294:18571-85. [PMID: 31636120 DOI: 10.1074/jbc.REV119.007060] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 12.0] [Reference Citation Analysis]
13 Lappano R, Mallet C, Rizzuti B, Grande F, Galli GR, Byrne C, Broutin I, Boudieu L, Eschalier A, Jacquot Y, Maggiolini M. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells. Cells 2019;8:E590. [PMID: 31207943 DOI: 10.3390/cells8060590] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
14 Jabeen A, Ranganathan S. Applications of machine learning in GPCR bioactive ligand discovery. Curr Opin Struct Biol 2019;55:66-76. [PMID: 31005679 DOI: 10.1016/j.sbi.2019.03.022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]